These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28052681)

  • 1. Prognostic impact of LAT1 and CD98 expression in cutaneous angiosarcoma.
    Shimizu A; Kaira K; Okubo Y; Utsumi D; Yasuda M; Tominaga H; Oriuchi N; Kanai Y; Takahashi K; Ishikawa O
    Neoplasma; 2017; 64(2):283-288. PubMed ID: 28052681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.
    Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W
    Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
    Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
    Isoda A; Kaira K; Iwashina M; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Oyama T; Asao T; Matsumoto M; Sawamura M
    Cancer Sci; 2014 Nov; 105(11):1496-502. PubMed ID: 25220100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma.
    Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2013 Oct; 19(4):649-56. PubMed ID: 23516127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD98 is a promising prognostic biomarker in biliary tract cancer.
    Kaira K; Sunose Y; Oriuchi N; Kanai Y; Takeyoshi I
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):654-7. PubMed ID: 25475870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.
    Furuya M; Horiguchi J; Nakajima H; Kanai Y; Oyama T
    Cancer Sci; 2012 Feb; 103(2):382-9. PubMed ID: 22077314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
    Ogawa H; Kaira K; Motegi Y; Yokobori T; Takada T; Katoh R; Osone K; Takahashi R; Katayama C; Oyama T; Kanai Y; Yao T; Asao T; Kuwano H; Shirabe K
    Anticancer Res; 2019 May; 39(5):2535-2543. PubMed ID: 31092450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
    Zhang C; Xu J; Xue S; Ye J
    Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
    Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
    Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.
    Kaira K; Sunose Y; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Segawa A; Furuya M; Mori M; Oyama T; Takeyoshi I
    Br J Cancer; 2012 Aug; 107(4):632-8. PubMed ID: 22805328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas.
    Yanagisawa N; Hana K; Nakada N; Ichinoe M; Koizumi W; Endou H; Okayasu I; Murakumo Y
    Cancer Med; 2014 Oct; 3(5):1246-55. PubMed ID: 24890221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Exp Ther Med; 2010 Sep; 1(5):799-808. PubMed ID: 22993604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
    Kaira K; Sunose Y; Ohshima Y; Ishioka NS; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Yamaguchi A; Segawa A; Ide M; Mori M; Oyama T; Takeyoshi I
    BMC Cancer; 2013 Oct; 13():482. PubMed ID: 24131658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer.
    Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B
    Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.